Geron Corporation Class Action: Last Chance for Shareholders to Join Before May 12, 2025

Geron Corporation Class Action Notice

A class action lawsuit has been filed against Geron Corporation (NASDAQ: GERN), giving shareholders who acquired shares during a specified period an opportunity to get involved. The Gross Law Firm has issued a notice reminding shareholders of an upcoming deadline and important details surrounding the case.

Key Dates and Information

The class action specifically pertains to shareholders who purchased Geron shares between February 28, 2024, and February 25, 2025. The deadline to join this class action is May 12, 2025. Shareholders are encouraged to contact the Gross Law Firm to discuss the possibility of being appointed as lead plaintiff. However, it’s essential to note that being appointed as lead plaintiff is not necessary to participate in any recovery.

Allegations Against Geron Corporation

The lawsuit centers on allegations that Geron's executives misled investors about the company's product, Rytelo (imetelstat). According to the claims, they provided overly optimistic expectations regarding Rytelo's expected launch and its growth potential in combating unmet medical needs. The firm does claim that the company aimed to capture a significant market share targeting first-line ESA-ineligible patients, all while downplaying risks related to the drug's monitoring requirements and market competition.

On February 26, 2025, Geron announced its fourth-quarter financial results, revealing a significant stagnation in Rytelo's growth. The company attributed this decline to seasonality issues, competition, limited awareness surrounding the drug, and the burden imposed by the mandatory monitoring protocol. Consequently, this had a severe impact on Geron's stock price, which plummeted approximately 32.07%—from $2.37 per share on February 25 to $1.61 per share on February 26, 2025.

Steps for Interested Shareholders

To register for this class action, shareholders should submit their information through the provided link. Once registered, they will receive updates through a portfolio monitoring software designed to keep them informed on the case's progress. It’s crucial for shareholders affected by these events to act promptly as the deadline approaches.

The Gross Law Firm is dedicated to representing shareholders and aims to protect investors from fraudulent corporate practices. It is a nationally recognized firm committed to ensuring companies maintain ethical business standards and corporate responsibility. The firm seeks recovery for investors affected by misrepresented information, safeguarding their rights during legal proceedings.

In conclusion, if you purchased shares of Geron Corporation within the specific timeframe, now is the time to take action. With only a limited window before the May 12 deadline, ensure your voice is heard and consider your options with the Gross Law Firm. For more information, they can be reached at their New York office or via email.